Supportive Care in Cancer

, Volume 14, Issue 6, pp 489–491

Mucositis guidelines: what have they achieved, and where to from here?

Editorial

References

  1. 1.
    Rubenstein EB et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046CrossRefPubMedGoogle Scholar
  2. 2.
    Sonis ST et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025CrossRefPubMedGoogle Scholar
  3. 3.
    MASCC/ISOO, T.M.s.g.o. (2005) Summary of evidence-based clinical practice guidelines for care of patients with oral and gastrointestinal mucositis (2005 update). http://www.mascc.org
  4. 4.
    Keefe DM, Peterson DE, Schubert MM (2006) Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls. Support Cancer Therapy (in press)Google Scholar
  5. 5.
    Peterson D, Keefe D, Hutchins R, Schubert M (2005) Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer (in press)Google Scholar
  6. 6.
    Jones J, Avritsher E, Cooksley C, Michelet M, Nebiyou Bekele B, Elting L (2005) Epidemiology of treatment associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer (in press)Google Scholar
  7. 7.
    Anthony L, Bowen J, Garden A, Hewson I, Sonis S (2005) New thoughts on the pathobiology of regimen-related mucosal injury. Support Care Cancer (in press)Google Scholar
  8. 8.
    von Bultzingslowen I, Brennan M, Spijkervet F, Logan R, Stringer A, Raber J, Keefe DM (2005) Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer (in press)Google Scholar
  9. 9.
    Altman A, Barasch A, Damato K, Elad S, Epstein J (2005) Antimicrobials, mucosal coating agents, anesthetics, analgesics and nutritional supplements in alimentary mucositis. Support Care Cancer (in press)Google Scholar
  10. 10.
    Migliorati C, Oberle-Edwards L, Schubert M (2005) The role of alternative and natural agents, ice, and laser in the management of alimentary tract mucositis. Support Care Cancer (in press)Google Scholar
  11. 11.
    McGuire D, Johnson J, Wienandts P, Correa E (2005) The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer (in press)Google Scholar
  12. 12.
    McGuire DB, Johnson J, Migliorati C (2005) Promulgation of guidelines for mucositis management: educating health care professionals and patients. Support Care Cancer (in press)Google Scholar
  13. 13.
    Lalla R, Schubert M, Bensadoun R-J, Keefe D (2005) Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer (in press)Google Scholar
  14. 14.
    Bensadoun R-J, Schubert M, Lalla R, Keefe D (2005) Amifostine in the management of radiation-induced and chemotherapy-induced alimentary mucositis. Support Care Cancer (in press)Google Scholar
  15. 15.
    Keefe D, Lees J, Horvath N (2005) Palifermin for oral mucositis: the Royal Adelaide Hospital experience. Support Care Cancer (in press)Google Scholar
  16. 16.
    Brennan M, von Bultzingslowen I, Schubert M, Keefe D (2005) Alimentary mucositis: putting the guidelines into practice. Support Care Cancer (in press)Google Scholar
  17. 17.
    Spielberger R et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers (see comment). N Engl J Med 351(25):2590–2598CrossRefPubMedGoogle Scholar
  18. 18.
    Min D et al (2002) Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99(12):4592–4600CrossRefPubMedGoogle Scholar
  19. 19.
    Farrell CL et al (2002) The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 35(Suppl 1):78–85CrossRefPubMedGoogle Scholar
  20. 20.
    Gibson R, Keefe DM (2006) Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage, possible prevention strategies and treatment of the clinical problem. Support Care Cancer (in press)Google Scholar
  21. 21.
    The Antiemetic Study Group of MASCC (2005) The 2004 Perugia international antiemetic conference. Support Care Cancer 13(2):77–133CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Mucositis Study Group, MASCC/ISOO, Department of Medical OncologyRoyal Adelaide HospitalAdelaideAustralia

Personalised recommendations